Calculation of Filing Fee Tables


Form S-3
(Form Type)


PharmaCyte Biotech, Inc.
(Exact Name of Registrant as Specified in its Charter)


Table 1: Newly Registered and Carry Forward Securities



  Security Type Security
or Carry
Forward Rule
Registered (1)
Offering Price
Per Unit (2)
Offering Price (2)
Fee Rate Amount of
Registration Fee(1)(2)
Fees to Be Paid Equity Common stock, $0.0001 par value per share, underlying shares of convertible preferred stock 457(c) 1,678,558 $2.67 $4,481,749.86 $0.00011020 $493.89
  Equity Common stock, $0.0001 par value per share, underlying warrants 457(c) 1,678,558 $2.67 $4,481,749.86 $0.00011020 $493.89
Fees Previously Paid                
  Total Offering Amounts       $987.78
  Total Fees Previously Paid       $34,823.20
  Total Fee Offsets      
  Net Fee Due      


  (1) This Registration Statement registers 3,357,116 shares of common stock, par value $0.0001 per share (the “Common Stock”), of PharmaCyte Biotech, Inc. (the “Company”), issuable upon the conversion of certain shares of the Company’s Series B convertible preferred stock and upon exercise of certain warrants of the Company. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended, this Registration Statement shall also cover any additional shares of Common Stock that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.


  (2) Estimated in accordance with Rule 457(c) solely for purposes of calculating the registration fee on the basis of the average of the high and low prices of the Common Stock as reported on The Nasdaq Capital Market on August 1, 2023, a date within five business days prior to filing this Registration Statement.